Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Toxicol Sci ; 42(3): 259-265, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28496032

RESUMO

The farnesoid X receptor (FXR) is a bile acid-activated nuclear receptor which is abundant in the liver, intestine, and kidney. FXR is a pivotal factor in cholesterol/bile acid homeostasis but is involved in the growth of hepatocellular carcinoma cells. In the present study, we investigated whether FXR is also involved in the growth of renal adenocarcinoma cells. The cell growth of renal adenocarcinoma cell line ACHN was inhibited by FXR knockdown and stimulated by FXR ligand, while that of a normal renal cell-derived cell line, HK-2, was not affected. The carcinoma-specific stimulation of cell growth by FXR was found to arise from down-regulation of p53 and p21/Cip1 mRNA expression. Our study showed that FXR stimulates proliferation of renal adenocarcinoma cells and that FXR knockdown is useful for growth suppression of renal adenocarcinoma without cytotoxicity to normal renal cells.


Assuntos
Adenocarcinoma/patologia , Processos de Crescimento Celular/genética , Transformação Celular Neoplásica/genética , Neoplasias Renais/patologia , Receptores Citoplasmáticos e Nucleares/fisiologia , Adulto , Linhagem Celular , Inibidor de Quinase Dependente de Ciclina p21/genética , Regulação para Baixo , Expressão Gênica , Técnicas de Silenciamento de Genes , Humanos , Ligantes , Masculino , Pessoa de Meia-Idade , Proteína Supressora de Tumor p53/genética , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...